COVID-19 severity affected by proportion of antibodies targeting crucial viral protein
COVID-19 antibodies preferentially target a different part of the virus in mild cases of COVID-19 than they do in severe cases, and wane significantly within several months of infection, according to a new study by researchers at Stanford Medicine. The findings identify new links between the course of the disease and a patient’s immune response.…
Details